We are live on
!
Find out more
ACM
AIGH Capital Management Portfolio holdings
AUM
$733M
1-Year Est. Return
327.32%
This Fund
S&P 500
This Quarter
Est. Return
+27.18%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$555M
AUM Growth
+$80.2M
(+17%)
Cap. Flow
+$43.8M
Cap. Flow
% of AUM
7.88%
Top 10 Holdings %
Top 10 Hldgs %
63.82%
Holding
63
New
15
Increased
13
Reduced
3
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Photronics
PLAB
|
+$17.7M |
| 2 |
PDF Solutions
PDFS
|
+$16.1M |
| 3 |
CYBE
Cyberoptics Corp
CYBE
|
+$13.8M |
| 4 |
X4 Pharmaceuticals
XFOR
|
+$12.1M |
| 5 |
PDS Biotechnology
PDSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cohu
COHU
|
+$27.9M |
| 2 |
Rimini Street
RMNI
|
+$10.6M |
| 3 |
NVVE
Nuvve Holding Corp
NVVE
|
+$7.62M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$6.06M |
| 5 |
Lightpath Technologies
LPTH
|
+$5.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.4% |
| 2 | Healthcare | 24.43% |
| 3 | Industrials | 4.2% |
| 4 | Consumer Staples | 0.53% |
| 5 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$79.1B
| $172M | 30.97% |
750,000
+150,000
| +25% | +$33.7M |
|
|
EMKR
2
DELISTED
Emcore Corp
EMKR
| $31.1M | 5.59% |
337,015
| – | – |
|
|
DZSI
3
DELISTED
DZS Inc. Common Stock
DZSI
| $22.4M | 4.04% |
1,080,205
+356,282
| +49% | +$6.18M |
|
|
GRTX
4
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $19.9M | 3.58% |
2,022,889
+1,110,290
| +122% | +$9.02M |
|
5
Aspen Aerogels
ASPN
$338M
| $19.6M | 3.53% |
655,819
| – | – |
|
|
6
PDS Biotechnology
PDSB
$36.8M
| $18.8M | 3.39% |
+1,499,149
| New | +$11.7M |
|
|
CYBE
7
DELISTED
Cyberoptics Corp
CYBE
| $18.3M | 3.29% |
+445,591
| New | +$13.8M |
|
8
Aviat Networks
AVNW
$253M
| $18.2M | 3.27% |
554,682
| – | – |
|
|
9
Photronics
PLAB
$1.65B
| $17.8M | 3.21% |
+1,350,734
| New | +$17.7M |
|
|
10
PDF Solutions
PDFS
$1.72B
| $16.4M | 2.95% |
+900,000
| New | +$16.1M |
|
|
THER
11
DELISTED
THERATECHNOLOGIES INC COM
THER
| $14.3M | 2.58% |
3,575,733
| – | – |
|
|
OIIM
12
DELISTED
02Micro International
OIIM
| $13.2M | 2.37% |
1,828,199
| – | – |
|
|
ADMS
13
DELISTED
Adamas Pharmaceuticals
ADMS
| $12.9M | 2.32% |
2,435,743
+225,000
| +10% | +$1.16M |
|
14
SCYNEXIS
SCYX
$37.4M
| $10.9M | 1.96% |
+184,608
| New | +$11.6M |
|
15
Annovis Bio
ANVS
$72.7M
| $10.8M | 1.95% |
126,469
+9,213
| +8% | +$426K |
|
16
Puma Biotechnology
PBYI
$397M
| $10.2M | 1.84% |
1,114,427
+149,837
| +16% | +$1.52M |
|
|
AVYA
17
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $9.68M | 1.74% |
360,000
| – | – |
|
|
18
X4 Pharmaceuticals
XFOR
$375M
| $9.35M | 1.68% |
+47,963
| New | +$12.1M |
|
|
FOCL
19
EDAP TMS S.A.
FOCL
$235M
| $8.57M | 1.54% |
1,208,250
+125,000
| +12% | +$908K |
|
|
AVYA
20
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $8.07M | 1.45% |
300,000
| – | – |
|
|
BWAY
21
Brainsway
BWAY
$568M
| $7.75M | 1.4% |
1,520,000
| – | – |
|
22
Ondas Inc
ONDS
$3.86B
| $7.57M | 1.36% |
+952,867
| New | +$7.49M |
|
23
Franklin Wireless
FKWL
$27.2M
| $7.4M | 1.33% |
780,000
| – | – |
|
|
PRTK
24
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $6.29M | 1.13% |
922,779
+173,171
| +23% | +$1.4M |
|
|
ALNA
25
DELISTED
Allena Pharmaceuticals
ALNA
| $5.2M | 0.94% |
4,000,000
| – | – |
|
Similar funds
GFI
RP
IA
SI
GIC
CT
TWP
GWS
AIGH Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, AIGH Capital Management held 63 positions worth $555M, up 17% from $475M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
AIGH Capital Management deployed $43.8M of net new capital in Q2 2021, opening 15 new positions and adding to 13 existing holdings. Its largest new stake was Photronics: 1,350,734 shares worth $17.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was scPharmaceuticals, an estimated $1.28M trimmed.
- AIGH Capital Management's largest Q2 2021 buy was Photronics: 1,350,734 shares worth $17.8M.
- AIGH Capital Management added most to Galera Therapeutics, Inc. Common Stock in Q2 2021, an estimated $9.02M increase.
- AIGH Capital Management's biggest Q2 2021 reduction was scPharmaceuticals, cutting an estimated $1.28M.
- AIGH Capital Management fully exited Cohu in Q2 2021, selling an estimated $27.9M.
- AIGH Capital Management's ten largest holdings make up 64% of its $555M portfolio in Q2 2021.
- AIGH Capital Management opened 15 new positions and closed 16 in Q2 2021.
- AIGH Capital Management's portfolio value rose 17% quarter-over-quarter to $555M.
Based on AIGH Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.